Supplementary Experimental Procedures
MS/MS spectrum with backbone sequence annotated (J represents 2,4-diaminobutyrate, residue 1 is acylated with isooctanoic acid on the N-terminus). E. D-DAB 3 polymyxin B 1 (3) MS/MS spectrum with sidechain sequence annotated (J represents 2,4-diaminobutyrate, residue 1 is acylated with methyloctanoic acid on the N-terminus). F. D-DAB 3 polymyxin B 2 (4) MS/MS spectrum with sidechain sequence annotated (J represents 2,4-diaminobutyrate, residue 1 is acylated with isooctanoic acid on the Nterminus). G. Structure of polymyxin B 1 (3) and B 2 (4) with alternative fragmentation sites indicated. Fragmentation at purple line first results in the "backbone sequence" (residues 1-10). Fragmentation at green line first results in the "side chain sequence" (residues 1,2,3,4,10,9,8,7,6,5) . A. Chiral GC/MS trace of the constituent amino acids of D-DAB 3 -polymyxin B 2 (4) after acid hydrolysis of the peptide and subsequent derivatization as the pentafluoropropanamide isopropyl esters. B. Chiral GC/MS trace of the constituent amino acids of D-DAB 3 -polymyxin B 1 (3) after acid hydrolysis of the peptide and subsequent derivatization as the pentafluoropropanamide isopropyl esters, supplemented with the pentafluoropropanamide isopropyl ester of L-Thr. C. Chiral GC/MS trace of the constituent amino acids of D-DAB 3 -polymyxin B 2 (4) after acid hydrolysis of the peptide and subsequent derivatization as the pentafluoropropanamide isopropyl esters, supplemented with the pentafluoropropanamide isopropyl ester of LLeu. D. Chiral GC/MS trace of the constituent amino acids of D-DAB 3 -polymyxin B 1 (3) after acid hydrolysis of the peptide and subsequent derivatization as the pentafluoropropanamide isopropyl esters, supplemented with the pentafluoropropanamide isopropyl ester of D-Phe. E. Chiral GC/MS trace of the constituent amino acids of D-DAB 3 -polymyxin B 2 (4) after acid hydrolysis of the peptide and subsequent derivatization as the pentafluoropropanamide isopropyl esters, supplemented with the pentafluoropropanamide isopropyl ester of D-Dab. F. Chiral GC/MS trace of the constituent amino acids of D-DAB 3 -polymyxin B 2 (4) after acid hydrolysis of the peptide and subsequent derivatization as the pentafluoropropanamide isopropyl esters, supplemented with the pentafluoropropanamide isopropyl ester of LDab.
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